Head-to-head · Cost-Efficiency Index
Livea vs TideMedix
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Livea
Cost-first shoppers who want mN/WI residents wanting in-person clinic access, or telehealth patients in MN, WI, IA, or FL.
Visit LiveaTideMedix
Cost-first shoppers who want not recommended without calling to confirm the post-first-month price before signing up.
Visit TideMedixThe verdict
Livea and TideMedix tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with Livea (ranked #208, a hair above #214) — Cost-first shoppers who want mN/WI residents wanting in-person clinic access, or telehealth patients in MN, WI, IA, or FL. But TideMedix is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Livea.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Livea | TideMedix |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $99/mo (starting dose, compounded) | $99/mo (compounded) |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,188 | $1,188 |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | 4 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #208 | #214 |
Livea
62/100Where the value is
- Hybrid model offers real in-person clinic locations (8 across MN & WI), not telehealth-only
- Low headline starting price for semaglutide ($99/mo)
- Broader wellness service menu (nutrition, hormone therapy, NAD+) beyond just GLP-1s
The tradeoffs
- Tirzepatide explicitly flagged 'when available,' implying inconsistent supply
- No named medical director or specific compounding pharmacy partner
TideMedix
62/100Where the value is
- Repeated, prominent LegitScript certification claims
- Low advertised entry price ($99) for the first month
- Standard FDA compounding disclaimer present, suggesting legitimate compounded-drug awareness
The tradeoffs
- Headline $99 price is explicitly first-month-only; the ongoing monthly cost is never disclosed on the site
- No named medical director anywhere in the accessible content
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.